Will Glindmeyer

Will Glindmeyer is a Portfolio Manager at Adage Capital Management, where he specializes in biotechnology investments. In this capacity, he is responsible for identifying, evaluating, and managing investment opportunities across the biotechnology sector, leveraging his technical background and industry insights to inform portfolio decisions.

Before joining Adage Capital, Glindmeyer held roles as Vice President focused on biotech and pharma at Eaton Vance, Equity Research Associate at TimesSquare Capital Management, and Lead Reviewer at the FDA, all of which deepened his expertise in life sciences and healthcare investing. His board service at The Genesis Foundation for Children demonstrates a commitment to advancing medical and scientific causes beyond the investment community.

Glindmeyer holds a PhD and BS in Biomedical Engineering from Tulane University, equipping him with a deep understanding of drug development, medical devices, and biomedical innovation. His unique combination of scientific expertise and investment acumen positions him as a leading specialist in biotechnology equities and life sciences asset classes within the institutional investment landscape.